Share Twitter LinkedIn Facebook Email Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center addresses whether current data will change the way we treat colorectal cancer.
Pashtoon Kasi MD, MS – The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management – ASCO GI 2025 Colorectal 4 Mins Read
FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival Colorectal 3 Mins Read
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read